Characterization of a method using viable human target cells as the solid phase in a cell concentration fluorescence immunoassay (CCFIA) for screening of monoclonal antibodies and hybridoma supernatants-Reference-Cited by-同舟云学术

Characterization of a method using viable human target cells as the solid phase in a cell concentration fluorescence immunoassay (CCFIA) for screening of monoclonal antibodies and hybridoma supernatants

Published:1988-10 Issue:1 Volume:113 Page:123-135
ISSN:0022-1759
Container-title:Journal of Immunological Methods
language:en
Short-container-title:Journal of Immunological Methods

Author:

Avner Belina,Avner Barry P.,Gaydos Barbara,Liao S-K.,Thurman Gary B.,Oldham Robert K.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference19 articles.

1. Utilization of viable tumor cells in a particle concentration fluorescence immonoassay (PCFIA) for screening monoclonal antibodies (MOABS);Avner,1987

2. Development of therapeutic murine monoclonal antibodies to individual patient tumors;Avner,1987

3. Therapeutic murine monoclonal antibodies developed for individual cancer patients;Avner,1988

4. Characterization of monoclonal antibodies to cell surface antigens by particle concentration fluorescence immunoassay (PCFIA);Bethell;Biotechniques,1985

5. Detection of Monoclonal Antibodies by PCFIA Utilizing Bacteria as the Solid Phase;Dawson,1984

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Immunoconjugates;Principles of Cancer Biotherapy;2009

2. Drug immunoconjugates;Principles of Cancer Biotherapy;2003

3. Enzyme-Linked Immunosorbent Assay;Journal of Immunoassay;2000-05

4. Drug Immunoconjugates;Principles of Cancer Biotherapy;1998

5. The Cancer Biotherapy Research Group [CBRG], formerly the National Biotherapy Study Group [NBSG]: a 10-Year Perspective;Cancer Biotherapy and Radiopharmaceuticals;1997-08